Treatment

Kimozo 40 mg/ml clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedPhase I and Phase II (Integrated)- Other
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma
This study, BEACON 2, is looking for better ways to treat neuroblastoma, a type of cancer, in young people and adults when it has come back or not responded to previous treatments. It tests new combinations of existing medicines.
For: High risk relapsed neuroblastoma (relapsed or progressed after being defined as High Risk at any time following diagnosis or progressed/relapsed as high-risk neuroblastoma) · which is histologically proven as per International Neuroblastoma Staging System (INSS) definition.
France · Austria · Germany